Antimicrobial peptide of an anti-lipopolysaccharide factor modulates of the inflammatory response in RAW264.7 cells

Peptides

Volumn 31, Issue 7, 2010, Pages 1262-1272

  Lin, Ming Ching ^a,b   Lin, Shih Bin ^b   Lee, Shang Chun ^a   Lin, Ching Chun ^a   Hui, Cho Fat ^a   Chen, Jyh Yih ^a  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL ILAN UNIVERSITY   (Taiwan)

Author keywords

Anti lipopolysaccharide factor; Inflammatory response; Penaeus monodon; RAW264.7 cells

Indexed keywords

CALCIUM; CLUSTERIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUTAMYLCYSTEINYLLYSYLPHENYLALANYLTHREONYLVALYLLYSYLPROLYLTYROSYLLEUCYLLYSYLARGINYLPHENYLALANYLGLUTAMINYLVALYLTYROSYLTYROSYLLYSYLGLYCYLARGINYLMETHIONYLTRYPTOPHANYLCYSTEINYLPROLINE AMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN KINASE C; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG SYNTHESIS; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; MACROPHAGES; MICE; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

DECAPODA (CRUSTACEA); MAMMALIA; MURINAE; PENAEUS MONODON;

EID: 77952554073     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.04.004     Document Type: Article

References (56)

1. Beutler B., Milsark I.W., and Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869-871
2. Beutler B.A., Milsark I.W., and Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 135 (1985) 3972-3977
3. Brandenburg K., Koch M.H., and Seydel U. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur J Biochem 258 (1998) 686-695
4. Brown M.A., and Jones W.K. NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 9 (2004) 1201-1217
5. Carter A.B., Monick M.M., and Hunninghake G.W. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20 (1999) 751-758
6. Chen J.Y., Lin W.J., Wu J.L., Her G.M., and Hui C.F. Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells. Peptides 30 (2009) 2365-2373
7. Ciuffini L., Castellani L., Salvati E., Galletti S., Falcone G., and Alemà S. Delineating v-Src downstream effector pathways in transformed myoblasts. Oncogene 27 (2008) 528-539
8. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
9. Cooper A.M. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27 (2009) 393-422
10. Dankesreiter S., Hoess A., Schneider-Mergener J., Wagner H., and Miethke T. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 164 (2000) 4804-4811
11. de la Vega E., O'Leary N.A., Shockey J.E., Robalino J., Payne C., Browdy C.L., et al. Anti-lipopolysaccharide factor in Litopenaeus vannamei (LvALF): a broad spectrum antimicrobial peptide essential for shrimp immunity against bacterial and fungal infection. Mol Immunol 45 (2008) 1916-1925
12. Deng G.M. The role of bacterial DNA in inflammatory and allergic disease. Recent Pat Inflamm Allergy Drug Discov 2 (2008) 117-122
13. Diamond G., Kaiser V., Rhodes J., Russell J.P., and Bevins C.L. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun 68 (2000) 113-119
14. Gough M., Hancock R.E., and Kelly N.M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 64 (1996) 4922-4927
15. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., and Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3 (2002) 354-359
16. Hancock R.E., and Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 16 (1998) 82-88
17. Hancock R.E., and Scott M.G. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 (2000) 8856-8861
18. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162 (1999) 3749-3752
19. Imjongjirak C., Amparyup P., Tassanakajon A., and Sittipraneed S. Antilipopolysaccharide factor (ALF) of mud crab Scylla paramamosain: molecular cloning, genomic organization and the antimicrobial activity of its synthetic LPS binding domain. Mol Immunol 44 (2007) 3195-3203
20. Ji R.R., Gereau IV R.W., Malcangio M., and Strichartz G.R. MAP kinase and pain. Brain Res Rev 60 (2009) 135-148
21. Kanazawa N., Tashiro K., and Miyachi Y. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology 209 (2004) 179-190
22. Karl E., Warner K., Zeitlin B., Kaneko T., Wurtzel L., Jin T., et al. Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Res 65 (2005) 5063-5069
23. Lentsch A.B., Jordan J.A., Czermak B.J., Diehl K.M., Younkin E.M., Sarma V., et al. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 154 (1999) 239-247
24. Leslie D.B., Vietzen P.S., Lazaron V., Wasiluk K.R., and Dunn D.L. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor. Surg Infect (Larchmt) 7 (2006) 45-52
25. Li X., Lee J.W., Graves L.M., and Earp H.S. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17 (1998) 2574-2583
26. Lynn W.A. Anti-endotoxin therapeutic options for the treatment of sepsis. J Antimicrob Chemother 41 (1998) 71-80
27. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176 (2006) 2455-2464
28. Mookherjee N., Wilson H.L., Doria S., Popowych Y., Falsafi R., Yu J.J., et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J Leukoc Biol 80 (2006) 1563-1574
29. Moon S.E., Bhagavathula N., and Varani J. Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br J Cancer 87 (2002) 457-464
30. Motzkus D., Schulz-Maronde S., Heitland A., Schulz A., Forssmann W.G., Jübner M., et al. The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J 20 (2006) 1701-1702
31. Murakami T., Yomogida S., Someya A., Kuwahara-Arai K., Tamura H., and Nagaoka I. Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes. FEBS Lett 581 (2007) 140-144
32. Murakami T., Obata T., Kuwahara-Arai K., Tamura H., Hiramatsu K., and Nagaoka I. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Int Immunol 21 (2009) 905-912
33. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., et al. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167 (2001) 3329-3338
34. Nagoshi H., Inagawa H., Morii K., Harada H., Kohchi C., Nishizawa T., et al. Cloning and characterization of a LPS-regulatory gene having an LPS binding domain in kuruma prawn Marsupenaeus japonicus. Mol Immunol 43 (2006) 2061-2069
35. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 95 (1998) 3537-3542
36. Pan C.Y., Chao T.T., Chen J.C., Chen J.Y., Liu W.C., Lin C.H., et al. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice. Int Immunopharmacol 5 (2007) 687-700
37. Pan C.Y., Chen J.Y., Lin T.L., and Lin C.H. In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis. Peptides 30 (2009) 1058-1068
38. Paoletti I., Buommino E., Tudisco L., Baudouin C., Msika P., Tufano M.A., et al. Patented natural avocado sugars modulate the HBD-2 expression in human keratinocytes through the involvement of protein kinase C and protein tyrosine kinases. Arch Dermatol Res 302 3 (2010) 201-209
39. Ren J.D., Gu J.S., Gao H.F., Xia P.Y., and Xiao G.X. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo. Int Immunopharmacol 8 (2008) 775-781
40. Sano C., Shimizu T., and Tomioka H. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages. Cytokine 21 (2003) 38-42
41. Scapini P., Crepaldi L., Pinardi C., Calzetti F., and Cassatella M.A. CCL20/macrophage inflammatory protein-3alpha production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucyl-phenylalanine and IFN-gamma through independent mechanisms. Eur J Immunol 32 (2002) 3515-3524
42. Scott M.G., and Hancock R.E. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 20 (2000) 407-431
43. Scott M.G., Rosenberger C.M., Gold M.R., Finlay B.B., and Hancock R.E. An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J Immunol 165 (2000) 3358-3365
44. Somboonwiwat K., Marcos M., Tassanakajon A., Klinbunga S., Aumelas A., Romestand B., et al. Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon. Dev Comp Immunol 29 (2005) 841-851
45. Suzuki T., Kono H., Hirose N., Okada M., Yamamoto T., Yamamoto K., et al. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. J Immunol 165 (2000) 473-482
46. Tharntada S., Ponprateep S., Somboonwiwat K., Liu H., Söderhäll I., Söderhäll K., et al. Role of anti-lipopolysaccharide factor from the black tiger shrimp, Penaeus monodon, in protection from white spot syndrome virus infection. J Gen Virol 90 (2009) 1491-1498
47. Tsutsumi-Ishii Y., and Nagaoka I. NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 71 (2002) 154-162
48. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
49. Vallespi M.G., Glaria L.A., Reyes O., Garay H.E., Ferrero J., and Araña M.J. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Clin Diagn Lab Immunol 7 (2000) 669-675
50. Villalonga P., López-Alcalá C., Chiloeches A., Gil J., Marais R., Bachs O., et al. Calmodulin prevents activation of Ras by PKC in 3T3 fibroblasts. J Biol Chem 277 (2002) 37929-37935
51. Waage A., and Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med 167 (1988) 1987-1992
52. Wu G.S. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3 (2004) 156-161
53. Xu Y., Jagannath C., Liu X.D., Sharafkhaneh A., Kolodziejska K.E., and Eissa N.T. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27 (2007) 135-144
54. Yang Y., Boze H., Chemardin P., Padilla A., Moulin G., Tassanakajon A., et al. NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site. Biopolymers 91 (2009) 207-220
55. Zwerina J., Redlich K., Schett G., and Smolen J.S. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann NY Acad Sci 1051 (2005) 716-729
56. Guha M., O'Connell M.A., Pawlinski R., Hollis A., McGovern P., Yan S.F., et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98 5 (2001) 1429-1439